Cargando…

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis

Detalles Bibliográficos
Autores principales:	Trídico, Lívia Arroyo, Antonio, João Roberto, Mathias, Carlos Eduardo, Pozetti, Eurides Maria de Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2017
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674720/ https://www.ncbi.nlm.nih.gov/pubmed/29166526 http://dx.doi.org/10.1590/abd1806-4841.20176565

Ejemplares similares

Clouston Syndrome: 25-year follow-up of a patient
por: Trídico, Lívia Arroyo, et al.
Publicado: (2015)

Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients
por: Antonio, João Roberto, et al.
Publicado: (2016)

Computed tomography imaging findings in erythrodermic psoriasis treated with infliximab: A case report
por: Kurokawa, Ryo, et al.
Publicado: (2018)

Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report
por: Lu, Jiajing, et al.
Publicado: (2020)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo, Yang, et al.
Publicado: (2021)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Infliximab (Remicade) in the treatment of psoriatic arthritis
por: Mease, Philip
Publicado: (2006)

Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
por: Kurizky, Patricia Shu, et al.
Publicado: (2019)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
por: Rao, Suman, et al.
Publicado: (2020)

Organizing Pneumonia Complicated with Erythrodermic Psoriasis
por: Nakamura, Hiroyuki, et al.
Publicado: (2019)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
por: Noure, Lamya, et al.
Publicado: (2021)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2022)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2021)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
por: Rosenberg, Alexander, et al.
Publicado: (2014)

Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab
por: Tichy, Martin
Publicado: (2019)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Erythrodermic presentation of psoriasis in a patient treated with dupilumab
por: Tracey, Elisabeth H., et al.
Publicado: (2018)

Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy
por: Ellis, John, et al.
Publicado: (2019)

Erythrodermic psoriasis in post-coronavirus disease 2019 patient
por: Batubara, Irwan Saputra, et al.
Publicado: (2022)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
por: Okubo, Yukari, et al.
Publicado: (2022)

An Uncommon Presentation of Erythrodermic Psoriasis in a Patient Without a History of Psoriasis
por: Rendo, Matt, et al.
Publicado: (2019)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
por: Castro, Karla R., et al.
Publicado: (2011)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis
por: Hariman, Richard, et al.
Publicado: (2016)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
por: Matsuura-Otsuki, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hkf16lqq42jakgeicrulp1sfq8